Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family

Whole-genome sequencing methods in familial cancer are useful to unravel rare clinically important cancer predisposing variants. Here, we present improvements in our pedigree-based familial cancer variant prioritization pipeline referred as FCVPPv2, including 12 tools for evaluating deleteriousness...

Full description

Saved in:
Bibliographic Details
Main Authors: Kumar, Abhishek (Author) , Bandapalli, Obul Reddy (Author) , Paramasivam, Nagarajan (Author) , Giangiobbe, Sara (Author) , Diquigiovanni, Chiara (Author) , Bonora, Elena (Author) , Eils, Roland (Author) , Schlesner, Matthias (Author) , Hemminki, Kari (Author) , Försti, Asta (Author)
Format: Article (Journal)
Language:English
Published: 02 August 2018
In: Scientific reports
Year: 2018, Volume: 8
ISSN:2045-2322
DOI:10.1038/s41598-018-29952-z
Online Access:Verlag, Volltext: https://doi.org/10.1038/s41598-018-29952-z
Verlag: https://www.nature.com/articles/s41598-018-29952-z
Get full text
Author Notes:Abhishek Kumar, Obul Reddy Bandapalli, Nagarajan Paramasivam, Sara Giangiobbe, Chiara Diquigiovanni, Elena Bonora, Roland Eils, Matthias Schlesner, Kari Hemminki & Asta Försti
Description
Summary:Whole-genome sequencing methods in familial cancer are useful to unravel rare clinically important cancer predisposing variants. Here, we present improvements in our pedigree-based familial cancer variant prioritization pipeline referred as FCVPPv2, including 12 tools for evaluating deleteriousness and 5 intolerance scores for missense variants. This pipeline is also capable of assessing non-coding regions by combining FANTOM5 data with sets of tools like Bedtools, ChromHMM, Miranda, SNPnexus and Targetscan. We tested this pipeline in a family with history of a papillary thyroid cancer. Only one variant causing an amino acid change G573R (dbSNP ID rs145736623, NM_019609.4:exon11:c.G1717A:p.G573R) in the carboxypeptidase gene CPXM1 survived our pipeline. This variant is located in a highly conserved region across vertebrates in the peptidase_M14 domain (Pfam ID PF00246). The CPXM1 gene may be involved in adipogenesis and extracellular matrix remodelling and it has been suggested to be a tumour suppressor in breast cancer. However, the presence of the variant in the ExAC database suggests it to be a rare polymorphism or a low-penetrance risk allele. Overall, our pipeline is a comprehensive approach for prediction of predisposing variants for high-risk cancer families, for which a functional characterization is a crucial step to confirm their role in cancer predisposition.
Item Description:Gesehen am 14.11.2019
Physical Description:Online Resource
ISSN:2045-2322
DOI:10.1038/s41598-018-29952-z